Calendar

Baskin-Robbins Kicks Off Spooky Season with a Scary Good October Lineup

Monday, September 27, 2021 - 4:00pm

A scoop so good it's almost supernatural, Trick OREO Treat is sure to unearth that Halloween spirit.

Key Points: 
  • A scoop so good it's almost supernatural, Trick OREO Treat is sure to unearth that Halloween spirit.
  • Our iconic unicorn cake is getting all ghouled up as a Zombie Unicorn Cake for the spookiest season of the year.
  • The ideal size for a small coven or ghostly gathering, customize the Zombie Unicorn Cake with any Baskin-Robbins flavor including Trick OREO Treat for a wickedly good slice of fright-and-delight.
  • **
    Lovers of classic fall flavors are also in for a treat with the return of Pumpkin Cheesecake early this October.

Introducing the GUESS Originals x Anna Nicole Smith Collection by Cali Thornhill Dewitt for Fall 2021

Monday, September 27, 2021 - 4:00pm
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210927005532/en/
    Introducing the GUESS Originals x Anna Nicole Smith Collection by Cali Thornhill Dewitt for Fall 2021; Sydney Sweeney Makes Her Debut With GUESS Originals (Photo: Business Wire)
    The GUESS Originals x Anna Nicole Smith Collection by Cali Thornhill Dewitt takes a look back at the renowned GUESS imagery.
  • The collection and marketing were designed in collaboration with artist Cali Thornhill Dewitt, who helped create the 2018 Did You Miss Me?
  • Anna Nicole Smith GUESS Originals Capsule.
  • Pricing for the GUESS Originals x Anna Nicole Smith Collection by Cali Thornhill Dewitt ranges from $12 to $248 for shirts, jackets, denim, socks, hats, and handbags.

ARGO Named a 2021 Top 100 FinTech Provider by IDC Financial Insights

Monday, September 27, 2021 - 2:10pm

ARGO , the leading provider of high-value technology and analytical-sciences software for the financial services and healthcare industries, announced today that it has been named as a Top 100 FinTech Provider in the 2021 IDC FinTech Rankings , the most comprehensive vendor ranking for the financial services industry.

Key Points: 
  • ARGO , the leading provider of high-value technology and analytical-sciences software for the financial services and healthcare industries, announced today that it has been named as a Top 100 FinTech Provider in the 2021 IDC FinTech Rankings , the most comprehensive vendor ranking for the financial services industry.
  • Being named in the IDC FinTech Rankings is a significant accomplishment, demonstrating a providers commitment to the success of its financial institution clients, states Marc DeCastro, Research Director at IDC Financial Insights.
  • The IDC Fintech Rankings, now in its 18th year, is the global standard list of fintech providers to the industry, and we congratulate the 2021 winners.
  • We are honored to be included in the IDC FinTech ranking, said David Engebos, President and COO, ARGO.

Acasti Pharma Announces Initiation of Pharmacokinetic Bridging Study for GTX-104, the Company’s Lead Drug Candidate for the Treatment of Subarachnoid Hemorrhage

Monday, September 27, 2021 - 1:30pm

This latest study follows an earlier safety and dose-escalation crossover study conducted by Grace, which reported encouraging results.

Key Points: 
  • This latest study follows an earlier safety and dose-escalation crossover study conducted by Grace, which reported encouraging results.
  • Moreover, it could provide a more convenient dosing schedule that would be easier to administer to patients who are unconscious.
  • The PK bridging study is a single center, randomized, two-period crossover study in 50 healthy subjects.
  • Acasti is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases.

ShiftPixy Secures Virus-Killing Genesis One Technology to Make Restaurants Safer

Monday, September 27, 2021 - 1:00pm
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210927005266/en/
    Designed to meet the unique environmental and health issues for people in space, ShiftPixy has secured the exclusive distribution rights for the Genesis One anti-virus laser systems for use in restaurants and retail.
  • We were introduced to the Genesis One technology late last year and saw an opportunity to help our restaurant clients keep their dining rooms cleaner and safer in the face of COVID, said ShiftPixy CEO and Founder Scott Absher.
  • An independent lab has tested the Genesis One equipment and confirmed the technologys viral killing capability under realistic conditions.
  • ShiftPixy currently intends to offer the anti-viral system as an extension of its services to current clients initially with a major rollout planned for calendar 2022.

Med Manager is an Organization Tool That Truly Restores Control to the Patient

Monday, September 27, 2021 - 1:43pm

Med Manager solves this problem by offering an all-in-one solution to organizing medication, doctor's appointments, and medical history.

Key Points: 
  • Med Manager solves this problem by offering an all-in-one solution to organizing medication, doctor's appointments, and medical history.
  • A lack of proper organization can lead to duplicate or expired medications that could cause adverse reactions leading an emergency visit or worse.
  • Med Manager offers a wonderfully simple way to restore organization, from ordered pill bottles to recorded appointments and everything in between.
  • About Med Manager: Med Manager is a product created by Viva Life, Inc. After 30 years in the medical field, company founder Dr. Harry Wingate saw the critical need for a medicine organization solution.

Med Manager Provides a Central Story for Patients

Monday, September 27, 2021 - 1:38pm

Med Manager is an innovative product that offers a comprehensive solution to the issue of managing prescriptions.

Key Points: 
  • Med Manager is an innovative product that offers a comprehensive solution to the issue of managing prescriptions.
  • Med Manager was created by Dr. Harry Wingate after the ER physician had spent the betterpart of three decades witnessing how disorganized his patients' medications could get.
  • "There is no product that I'm aware of," Wingate explains, "that tries to organize patient's complex medication regimens and provides a central story for their critical information."
  • About Med Manager: Med Manager products are created by Viva Life, Inc. Viva Life was launched by Dr. Harry Wingate in 2017 after the entrepreneur had created his first Med Manager prototype three years earlier.

Harborside Expected to Transition to Domestic Issuer Status in United States

Monday, September 27, 2021 - 1:12pm

If and when the Transition is completed, the Company will be subject tothe U.S. Securities and Exchange Commission's ("SEC")reporting requirements applicable toU.S.domestic companies.

Key Points: 
  • If and when the Transition is completed, the Company will be subject tothe U.S. Securities and Exchange Commission's ("SEC")reporting requirements applicable toU.S.domestic companies.
  • The SEC's reporting requirements will require, among other things, Harborside's financial statements and financial data to be presented underU.S.GAAP.
  • This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian and United States securities legislation.
  • Cannabis remains a Schedule I drug under the US Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis in the United States.

iBio Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate Update

Monday, September 27, 2021 - 12:30pm

BRYAN, Texas, Sept. 27, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System®, today announced its financial results for the fiscal fourth quarter and year ended June 30, 2021.

Key Points: 
  • Fiscal Fourth Quarter and Recent Business Developments:
    In June 2021, iBio established a new drug discovery team based in San Diego.
  • Fiscal Fourth Quarter and Recent Corporate Developments:
    Throughout fiscal 2021 and FY22 year-to-date, iBio increased its bench strength and enhanced its leadership team to support its growth strategy.
  • R&D and G&A expenses for the fourth quarter and full fiscal year 2021 increased significantly over the comparable periods in fiscal year 2020.
  • G&A expense was up $10.6 million to $22.0 million in fiscal 2021, rising $3.5 million to $6.6 million in the fourth quarter.

IonQ Expected to Go Public With in Excess of $600 Million in Expected Gross Proceeds

Monday, September 27, 2021 - 1:00pm

I want to thank the entire IonQ team for their tireless effort and look forward to continuing to pave the future of quantum computing.

Key Points: 
  • I want to thank the entire IonQ team for their tireless effort and look forward to continuing to pave the future of quantum computing.
  • IonQ is a leader in quantum computing, utilizing a trapped-ion approach to create the worlds most powerful quantum computers.
  • IonQ is dedicated to making quantum computing not just the technology of the future, but increasingly, the cutting-edge technology of today.
  • Neither dMY nor IonQ gives any assurance that either dMY or IonQ, or the combined company, will achieve its expectations.